2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
565
Specimen Handling
494
Carboplatin
452
Magnetic Resonance Spectroscopy
444
Cyclophosphamide
421
Cisplatin
405
Radiotherapy
352
Bevacizumab
316
Gemcitabine
313
Paclitaxel
299
Biopsy
290
Drug Therapy
284
Blood Specimen Collection
249
Capecitabine
246
fludarabine
241
Oxaliplatin
241
Nivolumab
235
venetoclax
220
Injections
213
Docetaxel
211
Fluorouracil
206
Dexamethasone
187
Radiosurgery
182
Standard of Care
160
Rituximab
159
Pemetrexed
156
Surgical Procedures, Operative
149
atezolizumab
146
durvalumab
145
Leucovorin
140
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
belimumab
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled